# FDA Inspection 927312 - Lilly del Caribe, Inc - May 01, 2015

Source: https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/6547a79e-d33f-4ba7-b48a-eb9479700491
Source feed: FDA_Inspections

> FDA Inspection 927312 for Lilly del Caribe, Inc on May 01, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 927312
- Company Name: Lilly del Caribe, Inc
- Inspection Date: 2015-05-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1300794 - 2026-01-30](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/d9a41b15-225e-4c51-bfaf-91cb7e3c3d83)
- [FDA Inspection 1163359 - 2022-02-25](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/67a137fe-39cd-4944-a803-b07d21b0597d)
- [FDA Inspection 1097298 - 2019-07-12](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/a1a425a8-d9bf-46ef-9ec7-8b7fd47ad3fa)
- [FDA Inspection 1069938 - 2018-09-21](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/7a1e89bb-7296-474d-b52c-d1cb38dfd3bc)
- [FDA Inspection 1020761 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/d181624a-29e4-42de-b068-e183bfe32f1b)

Company: https://www.keypedia.com/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c